Topic Highlight
Copyright ©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Apr 21, 2014; 20(15): 4115-4127
Published online Apr 21, 2014. doi: 10.3748/wjg.v20.i15.4115
Hepatocellular carcinoma review: Current treatment, and evidence-based medicine
Ali Raza, Gagan K Sood
Ali Raza, Department of Internal Medicine, St. Luke’s Episcopal Hospital, Baylor College of Medicine, Houston, TX 77030, United States
Gagan K Sood, Division of Gastroenterology and Hepatology, Baylor College of Medicine, St. Luke’s Liver Center, Houston, TX 77030, United States
Author contributions: Raza A performed the data research and helped writing the manuscript; Sood GK designed the manuscript; performed the research; helped writing the manuscript and critically analyzed the manuscript.
Correspondence to: Gagan K Sood, MD, Division of Gastroenterology and Hepatology, Baylor College of Medicine, St. Luke’s Liver Center, 6620 Main Street, Suite 1425, Baylor Clinic, Houston, TX 77030, United States. gksood@bcm.edu
Telephone: +1-832-3551400 Fax: +1-713-6102479
Received: September 28, 2013
Revised: December 6, 2013
Accepted: March 6, 2014
Published online: April 21, 2014
Core Tip

Core tip: The article discusses the current evidence based treatment of hepatocellular carcinoma. Specific focus is placed on emerging systemic molecular targeted therapies.